Primary and salvage chemotherapy in advanced Hodgkin's disease: The Milan Cancer Institute experience-Reference-Cited by-同舟云学术

Primary and salvage chemotherapy in advanced Hodgkin's disease: The Milan Cancer Institute experience

Published:1991-01 Issue: Volume:2 Page:9-16
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bonadonna Gianni,Santoro Armando,Gianni A. Massimo,Viviani Simona,Siena Salvatore,Bregni Marco,Zucali Roberto,Lombardi Fabrizio,Bonfante Valeria,Gianni Luca,Valagussa Pinuccia

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/2/suppl_1/9/536917/2-suppl_1-9.pdf

Reference27 articles.

1. Tumor stem cell heterogeneity: Implications with respect to classification of cancers by chemotherapeutic effect;Skipper;Cancer Treat Rep,1984

2. Rationale for the use of alternating non-cross-resistant chemotherapy;Goldie;Cancer Treat Rep,1982

3. Hodgkin's Disease;Kaplan,1980

4. The influence of clinical trials on current treatment strategy for Hodgkin's disease;Bonadonna;Int J Radiat Oncol Biol Phys,1990

5. Twenty years of MOPP therapy for Hodgkin's disease;Longo;J Clin Oncol,1986

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Treatment of Hodgkin Lymphoma;Neoplastic Diseases of the Blood;2017-09-23

2. Advanced and Relapsed/Refractory Hodgkin Lymphoma: What Has Been Achieved During the Last 50 Years;Seminars in Hematology;2013-01

3. Diagnosis and Treatment of Hodgkin’s Lymphoma;Neoplastic Diseases of the Blood;2012-07-27

4. Phase II study of ABVd therapy for newly diagnosed clinical stage II–IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305);International Journal of Hematology;2010-11-16

5. Brazilian Experience Using High-Dose Sequential Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma;Clinical Lymphoma and Myeloma;2009-12